NO20000089L - Oppløsning av aminer - Google Patents

Oppløsning av aminer

Info

Publication number
NO20000089L
NO20000089L NO20000089A NO20000089A NO20000089L NO 20000089 L NO20000089 L NO 20000089L NO 20000089 A NO20000089 A NO 20000089A NO 20000089 A NO20000089 A NO 20000089A NO 20000089 L NO20000089 L NO 20000089L
Authority
NO
Norway
Prior art keywords
enantiomer
acid
compound
dextrorotatory
racemic mixture
Prior art date
Application number
NO20000089A
Other languages
English (en)
Other versions
NO314581B1 (no
NO20000089D0 (no
Inventor
Antoni Torrens-Jover
Jordi Frigola-Constansa
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of NO20000089D0 publication Critical patent/NO20000089D0/no
Publication of NO20000089L publication Critical patent/NO20000089L/no
Publication of NO314581B1 publication Critical patent/NO314581B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Saccharide Compounds (AREA)
  • Gyroscopes (AREA)
NO20000089A 1997-07-10 2000-01-07 Opplösning av aminer NO314581B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009701538A ES2130079B1 (es) 1997-07-10 1997-07-10 Resolucion de aminas
PCT/ES1998/000195 WO1999002500A1 (es) 1997-07-10 1998-07-06 Resolucion de aminas

Publications (3)

Publication Number Publication Date
NO20000089D0 NO20000089D0 (no) 2000-01-07
NO20000089L true NO20000089L (no) 2000-02-22
NO314581B1 NO314581B1 (no) 2003-04-14

Family

ID=8300022

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000089A NO314581B1 (no) 1997-07-10 2000-01-07 Opplösning av aminer

Country Status (12)

Country Link
US (1) US6187930B1 (no)
EP (1) EP1024137B1 (no)
JP (1) JP2001509505A (no)
AT (1) ATE250585T1 (no)
AU (1) AU8111798A (no)
CA (1) CA2295800A1 (no)
DE (1) DE69818495T2 (no)
DK (1) DK1024137T3 (no)
ES (2) ES2130079B1 (no)
NO (1) NO314581B1 (no)
PT (1) PT1024137E (no)
WO (1) WO1999002500A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5986135A (en) * 1998-09-25 1999-11-16 American Cyanamid Company Fungicidal trifluoromethylalkylamino-triazolopyrimidines
US6687187B2 (en) * 2000-08-11 2004-02-03 Phonak Ag Method for directional location and locating system
US20040142929A1 (en) * 2001-07-06 2004-07-22 Ramon Merce-Vidal Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
US7182210B2 (en) 2003-08-19 2007-02-27 Rock-Tenn Shared Services, Llc Adjustable shelving system
TW200533657A (en) * 2004-02-17 2005-10-16 Esteve Labor Dr Substituted pyrazoline compounds, their preparation and use as medicaments
EP1584335A3 (en) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising a carbinol composition and an opioid
ES2244326B1 (es) * 2004-04-05 2007-02-16 Laboratorios Del Dr. Esteve, S.A. Combinacion de substancias activas.
US20060040924A1 (en) * 2004-06-22 2006-02-23 Laboratorios Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of renal colic
EP1671953A1 (en) 2004-12-17 2006-06-21 Laboratorios Del Dr. Esteve, S.A. Process for obtaining cizolirtine and its enantiomers
EP1671968A1 (en) 2004-12-17 2006-06-21 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
EP1674465A1 (en) 2004-12-27 2006-06-28 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
WO2006122258A1 (en) * 2005-05-10 2006-11-16 Teva Pharmaceutical Industries Ltd. Method for the preparation of pregabalin and salts thereof
MX2007014129A (es) * 2005-05-10 2008-01-11 Teva Pharma Resolucion optica del acido 3-carbamoilmetil-5-metil hexanoico.
US7897589B2 (en) * 2005-07-15 2011-03-01 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1743890A1 (en) * 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. 4,5-Dihydro-1H-pyrazole derivatives, their preparation and use as medicaments
EP1743892A1 (en) * 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1757587A1 (en) * 2005-07-15 2007-02-28 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
MX2007005936A (es) * 2005-09-19 2007-07-04 Teva Pharma Una sintesis asimetrica del acido (s)-(+)-3-(aminometil)-5- metilhexanoico.
EP1820502A1 (en) 2006-02-10 2007-08-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising azolylcarbinol compounds
KR20100107500A (ko) * 2008-06-23 2010-10-05 테바 파마슈티컬 인더스트리즈 리미티드 (ｓ) 또는 (ｒ)-이소-부틸-글루타릭 에스테르의 입체선택적 효소 합성방법
EP2151234A1 (en) * 2008-07-28 2010-02-10 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical formulation comprising a CB1-receptor compound in a solid solution and/or solid dispersion
US20100291151A1 (en) * 2009-04-21 2010-11-18 Auspex Pharmaceuticals, Inc. 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor
JP2011057619A (ja) * 2009-09-10 2011-03-24 Tokai Univ 光学活性アミン化合物の製造方法、並びに、ジアステレオマー塩及びその製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742147B1 (fr) * 1995-12-06 1998-02-27 Esteve Labor Dr Procede de separation de carbinols
DE19601745C1 (de) * 1996-01-19 1997-10-09 Gruenenthal Gmbh Verfahren zur Racematspaltung von Tramadol

Also Published As

Publication number Publication date
AU8111798A (en) 1999-02-08
ATE250585T1 (de) 2003-10-15
DE69818495T2 (de) 2004-07-01
EP1024137B1 (en) 2003-09-24
ES2130079A1 (es) 1999-06-16
US6187930B1 (en) 2001-02-13
ES2130079B1 (es) 2000-01-16
NO314581B1 (no) 2003-04-14
DK1024137T3 (da) 2003-12-22
PT1024137E (pt) 2004-01-30
ES2209158T3 (es) 2004-06-16
WO1999002500A1 (es) 1999-01-21
NO20000089D0 (no) 2000-01-07
DE69818495D1 (de) 2003-10-30
JP2001509505A (ja) 2001-07-24
EP1024137A1 (en) 2000-08-02
CA2295800A1 (en) 1999-01-21

Similar Documents

Publication Publication Date Title
NO20000089L (no) Oppløsning av aminer
DK0574313T3 (da) 1,4-disubstituerede piperaziner til behandling af sygdomme i centralnervesystemet og neuroendocrine sygdomme
FI904327A0 (fi) N-substituerad-4-pyrimidinaminer och -pyrimidindiaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
YU92303A (sh) Optička rezolucija (1-benzil-4-metilpiperidin-3-il)- metilamina i njegova primena za dobijanje pirolo 2,3-pirimidin derivata protein kinaze
NO308508B1 (no) Anvendelse av levobupivacaine i enantiomert overskudd
DK165244C (da) Analogifremgangsmaade til fremstilling af 1,2,3-trisubstituerede indoler
LU92132I2 (fr) Sel d'aclidinium avec anion d'un acide mono ou polyvalent pharmaceutiquement acceptable particulièrement le bromure d'aclidinium
AU537414B2 (en) Pyroglutamic acid derivatives
FI861506A0 (fi) Foerfarande foer framstaellning av 1,2-ditiolan-3-pentansyra (tioktsyra).
ES2118814T3 (es) L-tartrato de (-)-(s)-2,8-dimetil-3-metilen-1-oxa-8-azaspiro(4,5)decano.
DE69231843D1 (de) Verfahren zur Herstellung von insektiziden, nematiziden und akariziden 2-Aryl-3-subst.-5- trifluormethylpyrrolen aus N-(subst. Benzyl)-2,2,2-trifluoracetimidoylchloriden
TW218016B (no)
YU47973B (sh) S-enantiomerni glutaramidi i postupak za njihovo dobijanje
ES2182086T3 (es) Nuevos derivados de peptidil-arginina aldehido.
ES2056072T3 (es) Procedimientos de preparacion del acido (+/-)-1,2-dihidro-3h-pirrolo (1,2-a) pirrol-1-carboxilico y compuestos relacionados.
DE3476520D1 (en) Use of a mixture of compounds for the manufacture of a composition for the treatment of buerger's disease
NO990159D0 (no) FremgangsmÕte for fremstilling av enantiomerisk anrikede N-acylazetidin-2-karboksylsyrer
NZ216613A (en) 7-fluoro prostacyclins and compositions
DE69405999D1 (de) Pharmazeutisch wirksame enantiomere
DK0426098T3 (da) Fremstilling af et lægemiddel til behandling af hyperphosphatæmisk status
DK549683A (da) 3-(1-phenethyl)-piperidin-3-yl)-2-phenyl-propionitrilderivatereller syreadditionssalte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
KR840007408A (ko) ±2-[(3,4-메틸렌디옥시)페네틸]-5-](3-카복스아미도-4-하이드록시)-α-하이드록시벤질] 피롤리딘의 제조방법
ES8703886A1 (es) Procedimiento para la obtencion de n-(diamino-fosfinil)halo-benzamidas
FR2385699A1 (fr) (-)-3-trifluoromethylsulfonyl-cyproheptadine
FI854460A0 (fi) Flytande, biologiskt aktiva sammansaettningar.